ADIAL PHARMACEUTICALS

adial-pharmaceuticals-logo

Adial Pharmaceuticals engages in the development of prescription medications for addiction and related disorders in the United States. The company's research pipeline includes AD04, a compound that completed the Phase IIb study for the treatment of alcohol use disorders; and AD01, which completed the Phase I clinical-stage for treating addictive behaviors.

#SimilarOrganizations #People #Financial #Event #Website #More

ADIAL PHARMACEUTICALS

Social Links:

Industry:
Addiction Treatment Biotechnology Health Care Pharmaceutical

Founded:
2010-01-01

Address:
Charlottesville, Virginia, United States

Country:
United States

Website Url:
http://www.adialpharma.com

Total Employee:
11+

Status:
Active

Contact:
434-422-9800

Email Addresses:
[email protected]

Total Funding:
34.32 M USD

Technology used in webpage:
Amazon Facebook Sharer Amazon California Region


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

towerview-health-logo

TowerView Health

TowerView Health develops an application for patients to manage medications.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.


Current Advisors List

kermit-anderson_image

Kermit Anderson Board Member @ Adial Pharmaceuticals
Board_member
2015-02-01

james-newman-jr_image

James Newman, Jr. Board Member @ Adial Pharmaceuticals
Board_member
2014-09-01

william-b-stilley_image

William B. Stilley Board Member @ Adial Pharmaceuticals
Board_member

robertson-gilliland_image

Robertson Gilliland Board Member @ Adial Pharmaceuticals
Board_member
2014-09-01

tony-goodman_image

Tony Goodman Board Member @ Adial Pharmaceuticals
Board_member
2017-07-01

kevin-schuyler_image

Kevin Schuyler Board Chairman @ Adial Pharmaceuticals
Board_member
2016-04-01

cary-claiborne_image

Cary Claiborne Board Member - Non Executive @ Adial Pharmaceuticals
Board_member
2021-11-01

Current Employees Featured

cary-claiborne_image

Cary Claiborne
Cary Claiborne Chief Executive Officer @ Adial Pharmaceuticals
Chief Executive Officer
2022-08-01

not_available_image

Bankole Johnson
Bankole Johnson Chairman @ Adial Pharmaceuticals
Chairman

not_available_image

Robert S. Capon
Robert S. Capon Vice Chairman @ Adial Pharmaceuticals
Vice Chairman

tony-goodman_image

Tony Goodman
Tony Goodman Chief Operating Officer @ Adial Pharmaceuticals
Chief Operating Officer
2024-01-01

Founder


not_available_image

Bankole Johnson

william-b-stilley_image

William B. Stilley

Stock Details


Company's stock symbol is NASDAQ:ADIL

Investors List

keystone-capital-partners_image

Keystone Capital Partners

Keystone Capital Partners investment in Post-IPO Equity - Adial Pharmaceuticals

richard-gilliam-2412_image

Richard Gilliam

Richard Gilliam investment in Post-IPO Equity - Adial Pharmaceuticals

bespoke-growth-partners_image

Bespoke Growth Partners

Bespoke Growth Partners investment in Post-IPO Equity - Adial Pharmaceuticals

keystone-capital-partners_image

Keystone Capital Partners

Keystone Capital Partners investment in Post-IPO Equity - Adial Pharmaceuticals

Official Site Inspections

http://www.adialpharma.com

  • Host name: 104.21.17.230
  • IP address: 104.21.17.230
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Adial Pharmaceuticals"

Adial Pharmaceuticals Inc. | ABOUT

Adial Pharmaceuticals was founded on November 23, 2010 in Charlottesville, Virginia to develop and commercialize medications for the treatment of addictions and related disorders.See details»

Adial Pharmaceuticals (NASDAQ: ADIL) - LinkedIn

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a ...See details»

Adial Pharmaceuticals

Jun 17, 2025 Adial Pharmaceuticals was founded in 2007 by Founding Chairman and CEO, William Stilley, M.D. The Company focuses on researching, developing and commercializing …See details»

Adial Pharmaceuticals - Crunchbase Company Profile

Adial Pharmaceuticals develops prescription medications for addiction and related disorders.See details»

ADial Pharmaceuticals • UVA Licensing & Ventures Group

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder “AUD” using our lead investigational new drug product, AD04.See details»

Company - Adial Pharmaceuticals Inc.

The Adial Vision To build the world’s leading pharmaceutical company focused on improving the quality of life of patients by preventing and treating addiction and other unmet medical needs.See details»

Adial Pharmaceuticals Inc. | MANAGEMENT

William B. Stilley has served as our Chief Executive Officer since co-founding the company in December 2010. Prior to joining Adial Pharmaceuticals, he was the Vice President, Business …See details»

Adial Pharmaceuticals Company Profile | Management and

Adial Pharmaceuticals Profile and History Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions.See details»

Adial Pharmaceuticals CEO and Key Executive Team - Craft.co

Adial Pharmaceuticals's Director is Tony Goodman. Other executives include Kevin Schuyler, Vice Chairman & Lead Independent Director; James W. Newman, Director and 5 others. See …See details»

Adial Pharmaceuticals Inc - Company Profile - GlobalData

Adial Pharmaceuticals Inc (Adial Pharma) is a clinical-stage biopharmaceutical company that develops therapeutic agents. The company's pipeline product include AD04, is for the …See details»

Adial Pharmaceuticals Inc. | BOARD OF DIRECTORS

He has guest lectured at the Darden School of Business in two courses on the management of life science companies, and serves on the Advisory Board of Virginia BIO, the statewide …See details»

Management Team Archives - Adial Pharmaceuticals Inc.

Cary Claiborne was named Chief Executive Officer in August 2022 after previously being appointed Chief Operating Officer in December 2021 and being named to the Board of …See details»

Adial Pharmaceuticals Reports Second Quarter 2025 Financial

1 day ago If you are interested in exploring partnership opportunities with Adial, we invite you to reach out to us ([email protected]) to discuss how our joint efforts can bring about …See details»

Contact - Adial Pharmaceuticals Inc.

Reach out to Adial Pharmaceuticals for media, investor, or business inquiries.See details»

Adial Corporate Presentartion - adialpharma.com

By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics, and healthcare, regulatory and scientific developments and …See details»

Adial Pharmaceuticals Reports Second Quarter 2025 Financial

10 hours ago GLEN ALLEN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company …See details»

Pipeline - Adial Pharmaceuticals Inc.

Discover Adial Pharmaceuticals’ development pipeline and its possible alcohol addiction treatment options.See details»

Adial Pharmaceuticals Inc. | About Adial

About Adial 16445 wp-singular,page-template-default,page,page-id-16445,wp-theme-bridge,bridge-core-2.5.8,ajax_fade,page_not_loaded,,qode-theme-ver-24.3,qode-theme …See details»

News / Events - Adial Pharmaceuticals Inc.

Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement Adial Pharmaceuticals …See details»

Adial Pharmaceuticals Inc. | TECHNOLOGY

The Company’s lead compound AD04 (“AD04”) is a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated in a Phase 3 …See details»

linkstock.net © 2022. All rights reserved